|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He Y, Zhang Q, Jiang R and Li Y: Role and
clinical significance of miRNA-381 in prostate cancer. Int J Clin
Exp Med. 10:2173–2180. 2017.
|
|
9
|
Formosa A, Markert EK, Lena AM, Italiano
D, Finazzi-Agro′ E, Levine AJ, B rnardini S, Garabadgiu AV, Melino
G and Candi E: MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c,
miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p,
mapped to the 14q32.31 locus, regulate proliferation, apoptosis,
migration and invasion in metastatic prostate cancer cells.
Oncogene. 33:5173–5182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liang Y, Zhao Q, Fan L, Zhang Z, Tan B,
Liu Y and Li Y: Down-regulation of MicroRNA-381 promotes cell
proliferation and invasion in colon cancer through up-regulation of
LRH-1. Biomed Pharmacother. 75:137–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Q, Zhao S, Pang X and Chi B:
MicroRNA-381 suppresses cell growth and invasion by targeting the
liver receptor homolog-1 in hepatocellular carcinoma. Oncol Rep.
35:1831–1840. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rothschild SI, Tschan MP, Jaggi R, Fey MF,
Gugger M and Gautschi O: MicroRNA-381 represses ID1 and is
deregulated in lung adenocarcinoma. J Thorac Oncol. 7:1069–1077.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao Q, Liu F, Ji K, Liu N, He Y, Zhang W
and Wang L: MicroRNA-381 inhibits the metastasis of gastric cancer
by targeting TMEM16A expression. J Exp Clin Cancer Res. 36:292017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xue Y, Xu W, Zhao W, Wang W, Zhang D and
Wu P: miR-381 inhibited breast cancer cells proliferation,
epithelial-to-mesenchymal transition and metastasis by targeting
CXCR4. Biomed Pharmacother. 86:426–433. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xia B, Li H, Yang S, Liu T and Lou G:
miR-381 inhibits epithelial ovarian cancer malignancy via YY1
suppression. Tumor Biol. 37:9157–9167. 2016. View Article : Google Scholar
|
|
16
|
Tang H, Liu X, Wang Z, She X, Zeng X, Deng
M, Liao Q, Guo X, Wang R, Li X, et al: Interaction of hsa-miR-381
and glioma suppressor LRRC4 is involved in glioma growth. Brain
Res. 1390:21–32. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen B, Duan L, Yin G, Tan J and Jiang X:
miR-381, a novel intrinsic WEE1 inhibitor, sensitizes renal cancer
cells to 5-FU by up-regulation of Cdc2 activities in 786-O. J
Chemother. 25:229–238. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets in drosophila. Genome Biol.
5:R12003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Porkka KP, Pfeiffer MJ, Waltering KK,
Vessella RL, Tammela TL and Visakorpi T: MicroRNA expression
profiling in prostate cancer. Cancer Res. 67:6130–6135. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ozen M, Creighton C, Ozdemir M and Ittmann
M: Widespread deregulation of microRNA expression in human prostate
cancer. Oncogene. 27:1788–1793. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen B and Liu B: miRNA-381 inhibits the
invasion of renal carcinoma and the underlying mechanisms. Zhong
Nan Da Xue Xue Bao. Yi Xue Ban. 40:1053–1059. 2015.(In
Chinese).
|
|
24
|
He X, Wei Y, Wang Y, Liu L, Wang W and Li
N: miR-381 functions as a tumor suppressor in colorectal cancer by
targeting Twist1. Onco Targets Ther. 9:1231–1239. 2016.PubMed/NCBI
|
|
25
|
Xu Y, Ohms SJ, Li Z, Wang Q, Gong G, Hu Y,
Mao Z, Shannon MF and Fan JY: Changes in the expression of miR-381
and miR-495 are inversely associated with the expression of the
MDR1 gene and development of multi-drug resistance. PLoS One.
8:e820622013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Heinlein CA and Chang C: Androgen receptor
(AR) coregulators: An overview. Endocr Rev. 23:175–200. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nadiminty N, Tummala R, Lou W, Zhu Y,
Zhang J, Chen X, eVere White RW, Kung HJ, Evans CP and Gao AC:
MicroRNA let-7c suppresses androgen receptor expression and
activity via regulation of Myc expression in prostate cancer cells.
J Biol Chem. 287:1527–1537. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Koochekpour S: Androgen receptor signaling
and mutations in prostate cancer. Asian J Androl. 12:639–657. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Marques RB, Dits NF, Erkens-Schulze S, van
IJcken WF, van Weerden WM and Jenster G: Modulation of androgen
receptor signaling in hormonal therapy-resistant prostate cancer
cell lines. PLoS One. 6:e231442011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dehm SM and Tindall DJ: Molecular
regulation of androgen action in prostate cancer. J Cell Biochem.
99:333–344. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin B, Wang J, Hong X, Yan X, Hwang D, Cho
JH, Yi D, Utleg AG, Fang X, Schones DE, et al: Integrated
expression profiling and ChIP-seq analyses of the growth inhibition
response program of the androgen receptor. PLoS One. 4:e65892009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ngan S, Stronach E, Photiou A, Waxman J,
Ali S and Buluwela L: Microarray coupled to quantitative RT-PCR
analysis of androgen-regulated genes in human LNCaP prostate cancer
cells. Oncogene. 28:2051–2063. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Heinlein CA and Chang C: Androgen receptor
in prostate cancer. Endocr Rev. 25:276–308. 2004. View Article : Google Scholar : PubMed/NCBI
|
